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Introduction: The Scottish Medicines Consortium (SMC) provides 
advice about clinical- and cost-effectiveness of newly licensed medi-
cines to the National Health Service (NHS) in Scotland. Since 2005, 
SMC has also provided early intelligence on medicines in develop-
mentthrough “Forward Look” (FL) reports. An investigation was 
undertaken to examine the completeness of FL and its usefulness to 
NHS Boards.
Patients (or Materials) and Methods: (1) Significant medicines 
(with the potential for net budget impact exceeding UK£500,000 
per annum at year 5 and/or significant service implications or orphan 
status) in FL reports (April 2006-October 2008) were compared 
with SMC advice. The actual launch date was compared with the 
FL predicted date to determine if the medicine was launched within 
expected time frames. (2) SMC advice (April 2006 - March 2010) 
for all medicines was compared with FL reports. For medicines that 
were not included in FL reports but accepted by SMC, those predicted 
by the manufacturer to have a budget impact ≥ UK£500,000 were 
identified. (3) Interviews were held with NHS Directors of Finance 
and Directors of Pharmacy to explore how FL reports were used at 
NHS Board level.
Results: (1) Of 116 significant FL medicines, 81 (70%) medicines 
were reviewed by SMC; only 4 of the medicines not reviewed by SMC 
had been launched in the United Kingdom. A total of 52 (45%) of 
the 116 medicines were launched within time frames predicted by FL. 
Of the remaining 64 medicines, 31 were launched out with expected 
time frames; 31 were not launched in the UK; and, for 2 medicines, 
data were unavailable. (2) Of 215 medicines that were reviewed by 
SMC (April 2006 to March 2010), 123 (57%) medicines had been 
included in FL reports. Of the 92 (43%) medicines that were not 
included in FL reports, 53 were accepted for use or restricted use by 
SMC, including 7 medicines that were predicted by the pharmaceuti-
cal company to have a net budget impact ≥ £500,000 at year 5. (3) 
The qualitative study demonstrated that although NHS Boards did 
not view FL as completely accurate, it was a useful source of intel-
ligence on medicines in the pipeline and an important starting point 
for local clinical engagement.
Conclusion: Most significant medicines in FL reports were subse-
quently launched and reviewed by SMC. As expected, it was challeng-
ing to accurately predict the launch date of medicines in development, 
with many launched out with expected timef rames and some not 
launched at all. Despite the limitations, FL was considered a useful 
source of intelligence on medicines in the pipeline.
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Introduction: Self-medication increases the risk of overuse and 
innappropriate use of antibiotics with implications for increasing 
adverse events, treatment costs for individuals, and selection of resist-
ant bacteria in whole population.The aim of the present study was to 
analyze the amount and structure of antibiotics issued on prescription 
and bought without prescription and to investigate the influence of 
the price on the antibiotics consumption.
Patients (or Materials) and Methods: The investigation was carried 
out in the Novi Sad (323,708 inhabitants), Serbia, over a 3-month 
period, from January 1 to March 31, 2008. The data on the number 
of packages, size of packages, and retail price of antibiotics (ATC 
group J01) were obtained from all state-owned and private pharma-
cies in Novi Sad. The data are presented as number of DDD/1000 
inhabitants/d. Costs/DDD was also calculated. The DU90% meth-
odology was used.
Results: Seventy-six percent of antibiotics were issued by prescrip-
tion, while 23.94% were bought without prescription in Novi Sad. 
Penicillins, cephalosporins, and macrolides were the most prescribed 
antibiotic classes. By contrast, penicillins, tetracyclines, and cepha-
losporins were the most frequently bought antibiotics. The average 
price per DDD within the DU90% segment was 0.90 Euro/DDD 
for antibiotics issued by prescription, while for antibiotics bought 
without prescription, it was only 0.65 Euro/DDD, indicating that 
less expensive drugs were bought without prescription. The cheap-
est drug/DDD was doxycyclin (0.21 Euro/DDD) and it occupied the 
first position among antibiotics bought without prescription, while 
it was on the third place among antibiotics issued by prescription. 
The most expensive drugs/DDD were azithromycin (1.52 Euro/DDD) 
and ciprofloxacine (1.52 Euro/DDD). They occupied the high fourth 
and the eighth place among antibiotics issued by prescription. Among 
antibiotics bought without prescription, these expensive drugs occu-
pied the seventh and the eighth places.
Conclusion: The results of our study clearly show that a significant 
amount of antibiotics were dispensed in the private pharmacies with-
out prescription in Novi Sad, Serbia. The financial aspects strongly 
influence the antibiotics consumption without prescription. The influ-
ence of administrative measures, introduced recently on the usage of 
antibiotics, will be follow. This work was supported by the Ministry 
of Science and Technological Development, Republic of Serbia, pro-
ject No. 41012.
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Introduction: In resource-poor countries, access to essential medicines, 
and suboptimal prescribing and use of medicines, are major public health 
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problems. Health workers lack updated medical information and treat-
ment support. Information and Communication Technology (ICT) could 
help tackle this. The impact of ICT on health systems in resource-poor 
countries is likely to be significant and transform the practice of medicine 
just as in high-income countries. However, research for finding the best 
way of doing this is needed. We assessed current approaches to and use 
of ICT among health workers in 2 rural districts of Tanzania in relation 
to the current drug distribution practices, as well as assessing the feasibil-
ity of using ICT to improve ordering and use of medicines.
Patients (or Materials) and Methods: This pilot study was conducted 
in 2010-2011, mapping the drug distribution chain in Tanzania, 
including its problems and barriers. The study was conducted in the 
Bunda and Serengeti districts, both part of a nationally supported 
ICT for rural development project. Health workers involved in drug 
procurement and use at 13 health facilities were interviewed on use 
of and knowledge about ICT, and their attitudes to its use in their 
daily work. They were also showed a potential ICT tool. This tool 
was a prototype application for android tables developed at the KTH 
Royal Institute of Technology in Stockholm. It consisted of 2 parts: 
inventory of drug stock and drug ordering, based on the Tanzanian 
Medical Stores Department (MSD) current paper forms.
Results: Interviewees reported stable drug supply as their main chal-
lenge: Drug supplies were often delayed and incomplete, resulting in 
stock-outs of essential medicines and equipment. The 20 interviewed 
health workers all used mobile phones, 8 of them smartphones that 
they connected to the Internet. All were very positive to the drug-
tracking application, and expressed a great need and wish for con-
tinuous medical education by distance.
Conclusion: New ways to order and distribute drugs, and support 
their use with updated knowledge are increasingly needed as soar-
ing medicine costs and chronic diseases add to the burden on health 
systems. This makes it important to test and evaluate how simple 
ICT technology integrated into the health care system can improve 
the quality of drug ordering, distribution, and use in rural parts of 
Africa. Studying this in a systematic way is pertinent; for example, 
using the Technology Acceptance Model (TAM).
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Introduction: ABCD(2) risk scores are used internationally to triage 
patients for investigation and treatment to reduce high risk of recur-
rent stroke syndromes. Cerebral microemboli detected by transcra-
nial Doppler (TCD) also predict increased risk of acute stroke. We 
studied whether ABCD(2) risk scores predict cerebral microemboli 
in patients with symptomatic carotid artery stenosis.
Patients (or Materials) and Methods: We studied from our Carotid 
Registry 171 patients presenting within 2 weeks of transient 
ischemic attack or minor stroke and found to have critical carotid 
artery stenosis (≥ 50%). Seventy-two (age, 70 [1] [SEM] years; male, 
49; Caucasian, 70) had cerebral microemboli on TCD, of whom 
60 (83%) underwent carotid endarterectomy (CEA). Ninety-nine 
(age, 71 [1]; male, 75; Caucasian, 92) had no TCD microemboli, 
of whom 82 (81%) underwent CEA (controls). Data were analyzed 
using chi-square and Mann-Whitney U tests and receiver operating 
characteristic (ROC) curves.
Results: There was no significant difference in the NICE criterion 
for early assessment (ABCD[2] risk score > 4) for patients with cer-
ebral microemboli versus those without microemboli (53/72 vs 68/99 
patients: odds ratio, 1.27 [95% CI, 0.65–2.50]; P = 0.485). After 
adjusting for preneurological event antiplatelet treatment (APT), 
area under the curve (AUC) of ROC for ABCD(2) risk score showed 
no prediction of cerebral microemboli (no pre-event APT, n = 51: 
AUC, 0.5 [95% CI, 0.325–0.656]; P = 0.914; pre-event APT, n = 
120: AUC, 0.5 [95% CI, 0.415–0.623]; P = 0.72). ABCD(2) risk 
score was < 4 both in 19/72 (26%) embolizing patients and in 31/99 
(31%) controls with critical carotid artery stenosis. The total esti-
mated preventable stroke rate for overlooked embolizing patients and 
those with nonembolizing critical carotid stenosis was 7.8% (95% 
CI, 3.8–11.9), estimated preventable national rate 6080 (95% CI, 
3950–8060), estimated annual UK health and societal cost £670m 
(95% CI, £323 m–£1.01 bn) versus total annual costs of Doppler 
imaging £16m.
Conclusion: ABCD(2) scores did not predict presence of cerebral 
microemboli or carotid disease in more than one quarter of patients 
with symptomatic critical carotid artery stenosis. Based on NICE 
guidelines (refer early if ABCD[2] > 4), assessment for urgent reduc-
tion of high stroke risk may be inappropriately delayed in many 
patients, with a large increase in preventable stroke and financial 
burden on society.
Disclosure of Interest: None declared.
PP070—HOSPITAL INFECTIONS IN INTERNAL 
MEDICINE INTENSIVE CARE CLINIC: INCIDENCE, 
CAUSATIVE AGENTS AND ANTIMICROBIAL 
CONSUMPTION
M. Miljkovic1; N. Konstantinovic1; A. Kovacevic1*; N. Rancic1;  
V. Suljagic2; B. Rakonjac3; S. Vukotic4; and V. Dragojevic-Simic1
1CENTER FOR CLINICAL PHARMACOLOGY; 2Department 
of Infection Control; 3Institute for Microbiology; and 4Emergency 
Internal Medicine Clinic, MILITARY MEDICAL ACADEMY, 
Belgrade, Serbia
Introduction: Hospital infections (HIs), frequently associated with hos-
pital treatment, are considered an important factor for increased hos-
pital morbidity, mortality, and overall costs. The aim of this study was 
to review the incidence of HIs, antimicrobial consumption and isolated 
bacteria strain resistance to antibiotics used in the Internal Medicine 
Intensive Care Clinic (IMICC) in the period from 2011 to 2012.
Patients (or Materials) and Methods: Antimicrobial consumption 
was expressed as a number of Defined Daily Doses per 100 bed days 
(DDD/100 b.d.), according to WHO ATC/DDD methodology. The 
incidence of HIs was expressed as the ratio of the total number of 
HIs to total number of patient days (p.d.) (× 1000). The analysis of 
the number of isolated bacterial strains and their resistance to anti-
microbials was based on the data from the Institute for Microbiology 
and Department of Infection Control in the hospital.
Results: Total antimicrobial consumption in IMICC increased from 
51.91 to 56.40 DDD/100 b.d. in 2012. Consumption of ciprofloxacin 
decreased for 20%, while vancomycine and meropenem consumption 
increased for 15% and 30% respectively, in comparison with year 
2011. Consumption of co-trimoxazole and amikacin remained the 
same during observed period. Total number of isolated bacterial strains 
was 237 and 304 in 2011 and 2012, respectively. Most frequently 
isolated bacteria (from blood culture – BC and nonquantitative low 
respiratory tract specimen – NQLRTS) was Acinetobacter spp., which 
resistance to meropenem increased in 2012 (from 50% to 56.10% of 
resistant strains), concomitantly with increased meropenem consump-
tion in this period. Resistance to ciprofloxacin remained high during 
observed period (86.67 vs 92.68% of resistant strains, respectively). 
